Query String: atorvastatin AT
Atorvastatin Calcium Atorvastatin BDBM50442868
BDBM50420200 ATORVASTATIN
Calcium (betaR,deltaR)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2) CHEMBL393220 US9006282, Atorvastatin calcium bis{(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate} BDBM50221993 atorvastatin calcium
Atorvastatin lactone 5-(4-Fluoro-phenyl)-1-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide BDBM50011032 US9006282, Example 3, Compound 2 CHEMBL333687
US9624159, Compound I(at) BDBM204986 US9249085, I(at)
AT-13148 BDBM50242733
AT-RA BDBM31891
BDBM293087 US10106501, Example AT
BDBM111444 Ser-aT (Compound 2)
BDBM111445 Tyr-aT (Compound 3)
BDBM747528 US12325697, Compound AT-1
US20240092799, Compound XXIX-AT BDBM660466
CI 981 (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid Lipitor CHEMBL1487 Atorvastatin (3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid US9353061, Atorvastatina BDBM22164
BDBM50243388 US10981896, Compound AT9283 AT-9283
Retinoic Acid US10188615, at-RA all-trans-retinoic acid at-RA BDBM323588 US10752616, Code No. atRA
Spara SPARFLOXACIN AT-4140 CI-978 BDBM50366822
- Lindsay, D; Jackson, P; Hindley, S; Bhamra, I Rosuvastatin and atorvastatin derivatives US Patent US9006282 (2015)
- Taldone, T; Zito, SW; Talele, TT Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin. Bioorg Med Chem Lett 18: 479-84 (2008)
- Staedler, D; Chapuis-Bernasconi, C; Dehmlow, H; Fischer, H; Juillerat-Jeanneret, L; Aebi, JD Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells. J Med Chem 55: 4990-5002 (2012)
- Wang, Z; Cheng, L; Kai, Z; Wu, F; Liu, Z; Cai, M Molecular modeling studies of atorvastatin analogues as HMGR inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations. Bioorg Med Chem Lett 24: 3869-76 (2014)
- Shahari, MSB; Dolzhenko, AV A closer look at N Eur J Med Chem 241: (2022)
- Carbajales, C; Azuaje, J; Oliveira, A; Loza, MI; Brea, J; Cadavid, MI; Masaguer, CF; García-Mera, X; Gutiérrez-de-Terán, H; Sotelo, E Enantiospecific Recognition at the A J Med Chem 60: 3372-3382 (2017)
- Weber, JT; O'Connor, MF; Hayataka, K; Colson, N; Medora, R; Russo, EB; Parker, KK Activity of Parthenolide at 5HT2A receptors. J Nat Prod 60: 651-3 (1997)
- Juillerat-Jeanneret, L The Other Angiotensin II Receptor: AT J Med Chem 63: 1978-1995 (2020)
- Mantlo, NB; Kim, D; Ondeyka, D; Chang, RS; Kivlighn, SD; Siegl, PK; Greenlee, WJ Imidazo[4,5-b]pyridine-based AT1 / AT2 angiotensin II receptor antagonists Bioorg Med Chem Lett 4: 17-22 (1994)
- Ragab, HM; Kim, JS; Dukat, M; Navarro, H; Glennon, RA Aryloxyethylamines: binding at alpha7 nicotinic acetylcholine receptors. Bioorg Med Chem Lett 16: 4283-6 (2006)
- Zhang, H; Yan, W; Sun, Y; Yuan, H; Su, L; Cao, X; Wang, P; Xu, Z; Hu, Y; Wang, Z; Wang, Y; Fu, K; Sun, Y; Chen, Y; Cheng, J; Guo, D Long Residence Time at the Vasopressin V J Med Chem 65: 7717-7728 (2022)
- Jörg, M; Glukhova, A; Abdul-Ridha, A; Vecchio, EA; Nguyen, AT; Sexton, PM; White, PJ; May, LT; Christopoulos, A; Scammells, PJ Novel Irreversible Agonists Acting at the A J Med Chem 59: 11182-11194 (2016)
- Bhat, R; Adam, AT; Lee, JJ; Gasiewicz, TA; Henry, EC; Rotella, DP Bioorg Med Chem Lett 24: 2263-6 (2014)
- Suthar, SK; Bansal, S; Alam, MM; Jaiswal, V; Tiwari, A; Chaudhary, A; Alex, AT; Joseph, A Bioorg Med Chem Lett 25: 5281-5 (2015)
- Yu, M; Teo, T; Yang, Y; Li, M; Long, Y; Philip, S; Noll, B; Heinemann, GK; Diab, S; Eldi, P; Mekonnen, L; Anshabo, AT; Rahaman, MH; Milne, R; Hayball, JD; Wang, S Eur J Med Chem 214: (2021)
- Popowycz, F; Gerber-Lemaire, S; Demange, R; Rodriguez-García, E; Asenjo, AT; Robina, I; Vogel, P Bioorg Med Chem Lett 11: 2489-93 (2001)
- Ayoub, AT; Abou El-Magd, RM; Xiao, J; Lewis, CW; Tilli, TM; Arakawa, K; Nindita, Y; Chan, G; Sun, L; Glover, M; Klobukowski, M; Tuszynski, J J Med Chem 59: 9532-9540 (2016)
- Davey, MS; Malde, R; Mykura, RC; Baker, AT; Taher, TE; Le Duff, CS; Willcox, BE; Mehellou, Y J Med Chem 61: 2111-2117 (2018)
- Güzel, O; Maresca, A; Scozzafava, A; Salman, A; Balaban, AT; Supuran, CT J Med Chem 52: 4063-7 (2009)
- Baviskar, AT; Banerjee, UC; Gupta, M; Singh, R; Kumar, S; Gupta, MK; Kumar, S; Raut, SK; Khullar, M; Singh, S; Kumar, R Bioorg Med Chem 21: 5782-93 (2013)
- Caldwell, RD; Qiu, H; Askew, BC; Bender, AT; Brugger, N; Camps, M; Dhanabal, M; Dutt, V; Eichhorn, T; Gardberg, AS; Goutopoulos, A; Grenningloh, R; Head, J; Healey, B; Hodous, BL; Huck, BR; Johnson, TL; Jones, C; Jones, RC; Mochalkin, I; Morandi, F; Nguyen, N; Meyring, M; Potnick, JR; Santos, DC; Schmidt, R; Sherer, B; Shutes, A; Urbahns, K; Follis, AV; Wegener, AA; Zimmerli, SC; Liu-Bujalski, L J Med Chem 62: 7643-7655 (2019)
- Sharma, KK; Cassell, RJ; Meqbil, YJ; Su, H; Blaine, AT; Cummins, BR; Mores, KL; Johnson, DK; van Rijn, RM; Altman, RA RSC Med Chem 12: 1958-1967 (2021)
- Bockus, AT; Leung, SF; Earp, DJ; Garcia Dominguez, PS; Spellmeyer, DC; Hernandez, L; Baldomero, MP; Gleason, CE; Walton, BF; Singh, R; Aggen, JB; Dupper, NJ; Shapiro, JA; Kreatsoulas, C; Bambal, RB; Fung, CC; Ramaseshan, M US Patent US20240218021 (2024)
- Nikpour, M; Sadeghian, H; Saberi, MR; Nick, RS; Seyedi, SM; Hosseini, A; Parsaee, H; Bozorg, AT Bioorg Med Chem 18: 855-62 (2010)
- Burnett, JC; Ruthel, G; Stegmann, CM; Panchal, RG; Nguyen, TL; Hermone, AR; Stafford, RG; Lane, DJ; Kenny, TA; McGrath, CF; Wipf, P; Stahl, AM; Schmidt, JJ; Gussio, R; Brunger, AT; Bavari, S J Biol Chem 282: 5004-14 (2007)
- Jorgensen, M; Bruun, AT; Rasmussen, LK US Patent US9056863 (2015)
- Bacalhau, P; San Juan, AA; Marques, CS; Peixoto, D; Goth, A; Guarda, C; Silva, M; Arantes, S; Caldeira, AT; Martins, R; Burke, AJ Bioorg Chem 67: 1-8 (2016)
- Martínez-Bailén, M; Carmona, AT; Cardona, F; Matassini, C; Goti, A; Kubo, M; Kato, A; Robina, I; Moreno-Vargas, AJ Eur J Med Chem 192: (2020)
- VanAtten, MK; Ensinger, CL; Chiu, AT; McCall, DE; Nguyen, TT; Wexler, RR; Timmermans, PB J Med Chem 36: 3985-92 (1994)
- Cordeiro, AT; Thiemann, OH; Michels, PA Bioorg Med Chem 17: 2483-9 (2009)
- Dharmaraja, AT J Med Chem 60: 3221-3240 (2017)
- Van Zandt, MC; Jones, ML; Gunn, DE; Geraci, LS; Jones, JH; Sawicki, DR; Sredy, J; Jacot, JL; Dicioccio, AT; Petrova, T; Mitschler, A; Podjarny, AD J Med Chem 48: 3141-52 (2005)
- Barton, NP; Bellenie, BR; Doran, AT; Emmons, AJ; Heer, JP; Salvagno, CM Bioorg Med Chem Lett 19: 528-32 (2008)
- Takahata, H; Takahashi, S; Azer, N; Eldefrawi, AT; Eldefrawi, ME Bioorg Med Chem Lett 10: 1293-5 (2000)
- Muddana, HS; Fenley, AT; Mobley, DL; Gilson, MK J Comput Aided Mol Des 28: 305-17 (2014)
- TERSTIEGE, I; GARRISON, AT; MURPHY, JJ; KWAPIEN, K US Patent US20240374588 (2024)
- Garrison, AT; Orsi, DL; Capstick, RA; Whomble, D; Li, J; Carter, TR; Felts, AS; Vinson, PN; Rodriguez, AL; Han, A; Hajari, K; Cho, HP; Teal, LB; Ragland, MG; Ghamari-Langroudi, M; Bubser, M; Chang, S; Schnetz-Boutaud, NC; Boutaud, O; Blobaum, AL; Foster, DJ; Niswender, CM; Conn, PJ; Lindsley, CW; Jones, CK; Han, C J Med Chem 65: 6273-6286 (2022)
- Ge, J; Normant, E; Porter, JR; Ali, JA; Dembski, MS; Gao, Y; Georges, AT; Grenier, L; Pak, RH; Patterson, J; Sydor, JR; Tibbitts, TT; Tong, JK; Adams, J; Palombella, VJ J Med Chem 49: 4606-15 (2006)
- Ghisaidoobe, AT; van den Berg, RJ; Butt, SS; Strijland, A; Donker-Koopman, WE; Scheij, S; van den Nieuwendijk, AM; Koomen, GJ; van Loevezijn, A; Leemhuis, M; Wennekes, T; van der Stelt, M; van der Marel, GA; van Boeckel, CA; Aerts, JM; Overkleeft, HS J Med Chem 57: 9096-104 (2014)
- Morriello, GJ; Dwyer, MP; Chen, Y; Ginetti, AT; Xu, S; Lu, J; Abeywickrema, P; Wang, D; Crespo, A; Cabalu, TD; Wilson, JE; Stachel, SJ; Paone, DV; Sinz, C Bioorg Med Chem Lett 44: (2021)
- Arasappan, A; Bell, IM; Breslin, MJ; Bungard, CJ; Burgey, CS; Chobanian, HR; Cox, JM; Ginnetti, AT; Guiadeen, DG; Jones, KL; Layton, ME; Liu, H; Liu, J; Perkins, JJ; Stachel, SJ; Suen-Lai, LM; Wu, Z US Patent US11377438 (2022)
- Dresser, MJ; Xiao, G; Leabman, MK; Gray, AT; Giacomini, KM Pharm Res 19: 1244-7 (2002)
- Gandour, RD; Leung, OT; Greway, AT; Ramsay, RR; Nic a'Bháird, N; Fronczek, FR; Bellard, BM; Kumaravel, G J Med Chem 36: 237-42 (1993)
- Semenov, VE; Zueva, IV; Lushchekina, SV; Lenina, OA; Gubaidullina, LM; Saifina, LF; Shulaeva, MM; Kayumova, RM; Saifina, AF; Gubaidullin, AT; Kondrashova, SA; Latypov, SK; Masson, P; Petrov, KA Eur J Med Chem 185: (2020)
- Mesleh, MF; Cross, JB; Zhang, J; Kahmann, J; Andersen, OA; Barker, J; Cheng, RK; Felicetti, B; Wood, M; Hadfield, AT; Scheich, C; Moy, TI; Yang, Q; Shotwell, J; Nguyen, K; Lippa, B; Dolle, R; Ryan, MD Bioorg Med Chem Lett 26: 1314-8 (2016)
- Rashamuse, TJ; Harrison, AT; Mosebi, S; van Vuuren, S; Coyanis, EM; Bode, ML Bioorg Med Chem 28: (2020)
- Heimburg, T; Chakrabarti, A; Lancelot, J; Marek, M; Melesina, J; Hauser, AT; Shaik, TB; Duclaud, S; Robaa, D; Erdmann, F; Schmidt, M; Romier, C; Pierce, RJ; Jung, M; Sippl, W J Med Chem 59: 2423-35 (2016)
- Savoy, EA; Olatunji, FP; Mesbahi, N; Ballard, RK; Lovingier, CL; Hendricksen, AT; Fulton, MD; Berkman, CE Bioorg Med Chem Lett 101: (2024)
- Lloyd, MG; Huckvale, R; Cheung, KJ; Rodrigues, MJ; Collie, GW; Pierrat, OA; Gatti Iou, M; Carter, M; Davis, OA; McAndrew, PC; Gunnell, E; Le Bihan, YV; Talbot, R; Henley, AT; Johnson, LD; Hayes, A; Bright, MD; Raynaud, FI; Meniconi, M; Burke, R; van Montfort, RLM; Rossanese, OW; Bellenie, BR; Hoelder, S J Med Chem 64: 17079-17097 (2021)
- Klein-Júnior, LC; Cretton, S; Allard, PM; Genta-Jouve, G; Passos, CS; Salton, J; Bertelli, P; Pupier, M; Jeannerat, D; Heyden, YV; Gasper, AL; Wolfender, JL; Christen, P; Henriques, AT J Nat Prod 80: 3032-3037 (2017)
- Rusche, JR; Peet, NP; Hopper, AT US Patent US9265734 (2016)
- Tsai, WC; Gilbert, NC; Ohler, A; Armstrong, M; Perry, S; Kalyanaraman, C; Yasgar, A; Rai, G; Simeonov, A; Jadhav, A; Standley, M; Lee, HW; Crews, P; Iavarone, AT; Jacobson, MP; Neau, DB; Offenbacher, AR; Newcomer, M; Holman, TR Bioorg Med Chem 46: (2021)
- Jiao, GS; Kim, S; Moayeri, M; Thai, A; Cregar-Hernandez, L; McKasson, L; O'Malley, S; Leppla, SH; Johnson, AT Bioorg Med Chem Lett 28: 134-139 (2018)
- Hamdy, R; Ziedan, NI; Ali, S; Bordoni, C; El-Sadek, M; Lashin, E; Brancale, A; Jones, AT; Westwell, AD Bioorg Med Chem Lett 27: 1037-1040 (2017)
- Clark, RD; Repke, DB; Kilpatrick, AT; Brown, CM; MacKinnon, AC; Clague, RU; Spedding, M J Med Chem 32: 2034-6 (1989)
- Cammarano, CM; Christopher, MP; Dinsmore, C; Doll, RJ; Fradera Llinas, FX; Li, C; Machacek, M; Martinez, M; Nair, LG; Pan, W; Reutershan, MH; Shizuka, M; Steinhuebel, DP; Sun, B; Thompson, CF; Trotter, BW; Wang, Y; Yang, L; Bogen, SL; Voss, ME; Panda, J; Kurissery, AT US Patent US9540377 (2017)
- Harper, AR; Le, AT; Mather, T; Burgett, A; Berry, W; Summers, JA Bioorg Med Chem 26: 5766-5779 (2018)
- Futatsugi, K; Cabral, S; Kung, DW; Huard, K; Lee, E; Boehm, M; Bauman, J; Clark, RW; Coffey, SB; Crowley, C; Dechert-Schmitt, AM; Dowling, MS; Dullea, R; Gosset, JR; Kalgutkar, AS; Kou, K; Li, Q; Lian, Y; Loria, PM; Londregan, AT; Niosi, M; Orozco, C; Pettersen, JC; Pfefferkorn, JA; Polivkova, J; Ross, TT; Sharma, R; Stock, IA; Tesz, G; Wisniewska, H; Goodwin, B; Price, DA J Med Chem 65: 15000-15013 (2022)
- Liu, F; Zhang, X; Weisberg, E; Chen, S; Hur, W; Wu, H; Zhao, Z; Wang, W; Mao, M; Cai, C; Simon, NI; Sanda, T; Wang, J; Look, AT; Griffin, JD; Balk, SP; Liu, Q; Gray, NS ACS Chem Biol 8: 1423-8 (2013)
- Henke, BR; Consler, TG; Go, N; Hale, RL; Hohman, DR; Jones, SA; Lu, AT; Moore, LB; Moore, JT; Orband-Miller, LA; Robinett, RG; Shearin, J; Spearing, PK; Stewart, EL; Turnbull, PS; Weaver, SL; Williams, SP; Wisely, GB; Lambert, MH J Med Chem 45: 5492-505 (2002)
- Shih, NY; Aslanian, R; Lupo, AT; Orlando, S; Piwinski, JJ; Green, MJ; Ganguly, AK; West, R; Tozzi, S; Kreutner, W; Hey, JA Bioorg Med Chem Lett 8: 243-8 (1999)
- Chen, F; Hancock, CN; Macias, AT; Joh, J; Still, K; Zhong, S; MacKerell, AD; Shapiro, P Bioorg Med Chem Lett 16: 6281-7 (2006)
- Gogate, PN; Ethirajan, M; Kurenova, EV; Magis, AT; Pandey, RK; Cance, WG Eur J Med Chem 80: 154-66 (2014)
- Schweri, MM; Deutsch, HM; Massey, AT; Holtzman, SG J Pharmacol Exp Ther 301: 527-35 (2002)
- Das, B; Baidya, ATK; Mathew, AT; Yadav, AK; Kumar, R Bioorg Med Chem 56: (2022)
- Gromek, SM; deMayo, JA; Maxwell, AT; West, AM; Pavlik, CM; Zhao, Z; Li, J; Wiemer, AJ; Zweifach, A; Balunas, MJ Bioorg Med Chem 24: 5183-5196 (2016)
- Lawrence, NJ; Rennison, D; McGown, AT; Hadfield, JA Bioorg Med Chem Lett 13: 3759-63 (2003)
- Sabin, V; Horwell, DC; McKnight, AT; Broqua, P Bioorg Med Chem Lett 7: 291-296 (1997)
- Xiao, D; Palani, A; Aslanian, R; McKittrick, BA; McPhail, AT; Correll, CC; Phelps, PT; Anthes, JC; Rindgen, D Bioorg Med Chem Lett 19: 783-7 (2009)
- Li, W; Zheng, S; Higgins, M; Morra, RP; Mendis, AT; Chien, CW; Ojima, I; Mierke, DF; Dinkova-Kostova, AT; Honda, T J Med Chem 58: 4738-48 (2015)
- Large, JM; Birchall, K; Bouloc, NS; Merritt, AT; Smiljanic-Hurley, E; Tsagris, DJ; Wheldon, MC; Ansell, KH; Coombs, PJ; Kettleborough, CA; Whalley, D; Stewart, LB; Bowyer, PW; Baker, DA; Osborne, SA Bioorg Med Chem Lett 29: (2019)
- Andrews, SW; Aronow, S; Blake, JF; Brandhuber, BJ; Collier, J; Cook, A; Haas, J; Jiang, Y; Kolakowski, GR; McFaddin, EA; McKenney, ML; McNulty, OT; Metcalf, AT; Moreno, DA; Ramann, GA; Tang, TP; Ren, L; Walls, SM US Patent US10441581 (2019)
- Cortez, A; Li, Y; Miller, AT; Zhang, X; Yue, K; Maginnis, J; Hampton, J; Hall, de S; Shapiro, M; Nayak, B; D'Oro, U; Li, C; Skibinski, D; Mbow, ML; Singh, M; O'Hagan, DT; Cooke, MP; Valiante, NM; Wu, TY J Med Chem 59: 5868-78 (2016)
- NG AT
- Madu, IG; Namanja, AT; Su, Y; Wong, S; Li, YJ; Chen, Y ACS Chem Biol 8: 1435-41 (2013)
- Le Manach, C; Nchinda, AT; Paquet, T; Gonzàlez Cabrera, D; Younis, Y; Han, Z; Bashyam, S; Zabiulla, M; Taylor, D; Lawrence, N; White, KL; Charman, SA; Waterson, D; Witty, MJ; Wittlin, S; Botha, ME; Nondaba, SH; Reader, J; Birkholtz, LM; Jiménez-Díaz, MB; Martínez, MS; Ferrer, S; Angulo-Barturen, I; Meister, S; Antonova-Koch, Y; Winzeler, EA; Street, LJ; Chibale, K J Med Chem 59: 9890-9905 (2016)
- Neffe, AT; Bilang, M; Grüneberg, I; Meyer, B J Med Chem 50: 3482-8 (2007)
- Wambua, MK; Nalawansha, DA; Negmeldin, AT; Pflum, MK J Med Chem 57: 642-50 (2014)
- Daskalakis, N; Guttke, CD; Kwon, MC; Ferrante, LA; Packman, KE; Pietsch, EC; Philippar, U; Verhulst, TA; Ali-Ahmed, S; Bhogal, B; Sun, Y; Cai, W; Dai, X; Querolle, OA; Thuring, JW; Liu, Y; Liu, L; Xu, Y; Fu, L; Li, M; Fang, L; Deng, X; Ng, AT; Darville, NF; Pande, V US Patent US20240261292 (2024)
- Haviv, F; Fitzpatrick, TD; Nichols, CJ; Swenson, RE; Mort, NA; Bush, EN; Diaz, G; Nguyen, AT; Holst, MR; Cybulski, VA J Med Chem 36: 928-33 (1993)
- König, J; Cui, Y; Nies, AT; Keppler, D Am J Physiol Gastrointest Liver Physiol 278: 156-64 (2000)
- Asghar, A; Yousuf, M; Mubeen, H; Nazir, R; Haruna, K; Onawole, AT; Rasheed, L Bioorg Med Chem 27: 2397-2404 (2019)
- Maggiora, LL; Orawski, AT; Simmons, WH J Med Chem 42: 2394-402 (1999)
- Osuma, AT; Xu, X; Wang, Z; Van Camp, JA; Freiberg, GM Bioorg Med Chem Lett 29: (2019)
- Di Santo, R; Costi, R; Roux, A; Artico, M; Lavecchia, A; Marinelli, L; Novellino, E; Palmisano, L; Andreotti, M; Amici, R; Galluzzo, CM; Nencioni, L; Palamara, AT; Pommier, Y; Marchand, C J Med Chem 49: 1939-45 (2006)
- Rosowsky, A; Papoulis, AT; Queener, SF J Med Chem 41: 913-8 (1998)
- Wurz, RP; Pettus, LH; Ashton, K; Brown, J; Chen, JJ; Herberich, B; Hong, FT; Hu-Harrington, E; Nguyen, T; St Jean, DJ; Tadesse, S; Bauer, D; Kubryk, M; Zhan, J; Cooke, K; Mitchell, P; Andrews, KL; Hsieh, F; Hickman, D; Kalyanaraman, N; Wu, T; Reid, DL; Lobenhofer, EK; Andrews, DA; Everds, N; Guzman, R; Parsons, AT; Hedley, SJ; Tedrow, J; Thiel, OR; Potter, M; Radinsky, R; Beltran, PJ; Tasker, AS ACS Med Chem Lett 6: 987-92 (2015)
- Wen, Z; Salmaso, V; Jung, YH; Phung, NB; Gopinatth, V; Shah, Q; Patterson, AT; Randle, JCR; Chen, Z; Salvemini, D; Lieberman, DI; Whitehead, GS; Karcz, TP; Cook, DN; Jacobson, KA J Med Chem 65: 3434-3459 (2022)
- Sridhar, SN; Ginson, G; Venkataramana Reddy, PO; Tantak, MP; Kumar, D; Paul, AT Bioorg Med Chem 25: 609-620 (2017)
- Cao, J; Lever, JR; Kopajtic, T; Katz, JL; Pham, AT; Holmes, ML; Justice, JB; Newman, AH J Med Chem 47: 6128-36 (2004)
- Piala, AT; Akella, R; Potts, MB; Dudics-Giagnocavo, SA; He, H; Wei, S; White, MA; Posner, BA; Goldsmith, EJ Bioorg Med Chem Lett 26: 3923-7 (2016)
- Boström, J; Hogner, A; Llinàs, A; Wellner, E; Plowright, AT J Med Chem 55: 1817-30 (2012)
- Ursu, A; Illich, DJ; Takemoto, Y; Porfetye, AT; Zhang, M; Brockmeyer, A; Janning, P; Watanabe, N; Osada, H; Vetter, IR; Ziegler, S; Schöler, HR; Waldmann, H Cell Chem Biol 23: 494-507 (2016)
- Safonov, IG; Heerding, DA; Keenan, RM; Price, AT; Erickson-Miller, CL; Hopson, CB; Levin, JL; Lord, KA; Tapley, PM Bioorg Med Chem Lett 16: 1212-6 (2006)
- Kim, KS; Lu, S; Cornelius, LA; Lombardo, LJ; Borzilleri, RM; Schroeder, GM; Sheng, C; Rovnyak, G; Crews, D; Schmidt, RJ; Williams, DK; Bhide, RS; Traeger, SC; McDonnell, PA; Mueller, L; Sheriff, S; Newitt, JA; Pudzianowski, AT; Yang, Z; Wild, R; Lee, FY; Batorsky, R; Ryder, JS; Ortega-Nanos, M; Shen, H; Gottardis, M; Roussell, DL Bioorg Med Chem Lett 16: 3937-42 (2006)
- Volpini, R; Buccioni, M; Dal Ben, D; Lambertucci, C; Lammi, C; Marucci, G; Ramadori, AT; Klotz, KN; Cristalli, G J Med Chem 52: 7897-900 (2009)
- SLOMINSKI, AT; RAMAN, C; QUAYYUM, S US Patent US20240131036 (2024)
- Sands, AT; Bence, NF; Zapf, CW; Cohen, F; Wang, C; Cummins, T; Tanaka, H; Shunatona, H; Cardozo, M; Weiss, D; Gosling, J US Patent US11530229 (2022)
- Morriello, GJ; Wendt, HR; Bansal, A; Di Salvo, J; Feighner, S; He, J; Hurley, AL; Hreniuk, DL; Salituro, GM; Reddy, MV; Galloway, SM; McGettigan, KK; Laws, G; McKnight, C; Doss, GA; Tsou, NN; Black, RM; Morris, J; Ball, RG; Sanfiz, AT; Streckfuss, E; Struthers, M; Edmondson, SD Bioorg Med Chem Lett 21: 1865-70 (2011)
- Nandekar, PP; Khomane, K; Chaudhary, V; Rathod, VP; Borkar, RM; Bhandi, MM; Srinivas, R; Sangamwar, AT; Guchhait, SK; Bansal, AK Eur J Med Chem 115: 82-93 (2016)
- Manz, TD; Sivakumaren, SC; Yasgar, A; Hall, MD; Davis, MI; Seo, HS; Card, JD; Ficarro, SB; Shim, H; Marto, JA; Dhe-Paganon, S; Sasaki, AT; Boxer, MB; Simeonov, A; Cantley, LC; Shen, M; Zhang, T; Ferguson, FM; Gray, NS ACS Med Chem Lett 11: 346-352 (2020)
- Skudlarek, JW; DiMarco, CN; Babaoglu, K; Roecker, AJ; Bruno, JG; Pausch, MA; O'Brien, JA; Cabalu, TD; Stevens, J; Brunner, J; Tannenbaum, PL; Wuelfing, WP; Garson, SL; Fox, SV; Savitz, AT; Harrell, CM; Gotter, AL; Winrow, CJ; Renger, JJ; Kuduk, SD; Coleman, PJ Bioorg Med Chem Lett 27: 1364-1370 (2017)
- Parker, MA; Marona-Lewicka, D; Kurrasch, D; Shulgin, AT; Nichols, DE J Med Chem 41: 1001-5 (1998)
- McCluskey, A; Sim, AT; Sakoff, JA J Med Chem 45: 1151-75 (2002)
- Lin, Z; Marepally, SR; Ma, D; Myers, LK; Postlethwaite, AE; Tuckey, RC; Cheng, CY; Kim, TK; Yue, J; Slominski, AT; Miller, DD; Li, W J Med Chem 58: 7881-7 (2015)
- Savechenkov, PY; Chiara, DC; Desai, R; Stern, AT; Zhou, X; Ziemba, AM; Szabo, AL; Zhang, Y; Cohen, JB; Forman, SA; Miller, KW; Bruzik, KS Eur J Med Chem 136: 334-347 (2017)
- Taher, AT; Kadry, HH; Allarà, M; Di Marzo, V; Abadi, AH; Abouzid, KA J Enzyme Inhib Med Chem 28: 436-9 (2013)
- Beatty, JW; Lindsey, EA; Thomas-Tran, R; Debien, L; Mandal, D; Jeffrey, JL; Tran, AT; Fournier, J; Jacob, SD; Yan, X; Drew, SL; Ginn, E; Chen, A; Pham, AT; Zhao, S; Jin, L; Young, SW; Walker, NP; Leleti, MR; Moschütz, S; Sträter, N; Powers, JP; Lawson, KV J Med Chem 63: 3935-3955 (2020)
- Rheault, TR; Caferro, TR; Dickerson, SH; Donaldson, KH; Gaul, MD; Goetz, AS; Mullin, RJ; McDonald, OB; Petrov, KG; Rusnak, DW; Shewchuk, LM; Spehar, GM; Truesdale, AT; Vanderwall, DE; Wood, ER; Uehling, DE Bioorg Med Chem Lett 19: 817-20 (2009)
- Resetar, M; Tietcheu Galani, BR; Tsamo, AT; Chen, Y; Schachner, D; Stolzlechner, S; Mawouma Pagna, JI; Beniddir, MA; Kirchmair, J; Dirsch, VM J Nat Prod 86: 1901-1909 (2023)
- Vu, AT; Cohn, ST; Manas, ES; Harris, HA; Mewshaw, RE Bioorg Med Chem Lett 15: 4520-5 (2005)
- Niaz, H; Kashtoh, H; Khan, JA; Khan, A; Wahab, AT; Alam, MT; Khan, KM; Perveen, S; Choudhary, MI Eur J Med Chem 95: 199-209 (2015)
- Hammock, BD; Hwang, SH; Wecksler, AT; Morisseau, C US Patent US9029401 (2015)
- Wiener, JJ; Wickboldt, AT; Wiener, DK; Lee-Dutra, A; Edwards, JP; Karlsson, L; Nguyen, S; Sun, S; Jones, TK; Grice, CA Bioorg Med Chem Lett 20: 2375-8 (2010)
- Mesaros, EF; Thieu, TV; Wells, GJ; Zificsak, CA; Wagner, JC; Breslin, HJ; Tripathy, R; Diebold, JL; McHugh, RJ; Wohler, AT; Quail, MR; Wan, W; Lu, L; Huang, Z; Albom, MS; Angeles, TS; Wells-Knecht, KJ; Aimone, LD; Cheng, M; Ator, MA; Ott, GR; Dorsey, BD J Med Chem 55: 115-25 (2012)
- Wolman, AT; Gionfriddo, MR; Heindel, GA; Mukhija, P; Witkowski, S; Bommareddy, A; Vanwert, AL Drug Metab Dispos 41: 791-800 (2013)
- Hrib, NJ; Jurcak, JG; Burgher, KL; Conway, PG; Hartman, HB; Kerman, LL; Roehr, JE; Woods, AT J Med Chem 37: 2308-14 (1994)
- Lensing, CJ; Freeman, KT; Schnell, SM; Speth, RC; Zarth, AT; Haskell-Luevano, C J Med Chem 62: 144-158 (2019)
- Manetti, F; Cona, A; Angeli, L; Mugnaini, C; Raffi, F; Capone, C; Dreassi, E; Zizzari, AT; Tisi, A; Federico, R; Botta, M J Med Chem 52: 4774-85 (2009)
- Li, W; Zheng, S; Higgins, M; Morra, RP; Mendis, AT; Chien, CW; Ojima, I; Mierke, DF; Dinkova-Kostova, AT; Honda, T J Med Chem 58: 4738-48 (2015)
- Radwan, MM; ElSohly, MA; El-Alfy, AT; Ahmed, SA; Slade, D; Husni, AS; Manly, SP; Wilson, L; Seale, S; Cutler, SJ; Ross, SA J Nat Prod 78: 1271-6 (2015)
- Viira, B; Selyutina, A; García-Sosa, AT; Karonen, M; Sinkkonen, J; Merits, A; Maran, U Bioorg Med Chem 24: 2519-29 (2016)
- Severance, ZC; Nuñez, JI; Le-McClain, AT; Malinky, CA; Bensen, RC; Fogle, RS; Manginelli, GW; Sakers, SH; Falcon, EC; Bui, RH; Snead, KJ; Bourne, CR; Burgett, AWG J Med Chem 66: 3866-3875 (2023)
- Milbank, JB; Knauer, CS; Augelli-Szafran, CE; Sakkab-Tan, AT; Lin, KK; Yamagata, K; Hoffman, JK; Zhuang, N; Thomas, J; Galatsis, P; Wendt, JA; Mickelson, JW; Schwarz, RD; Kinsora, JJ; Lotarski, SM; Stakich, K; Gillespie, KK; Lam, WW; Mutlib, AE Bioorg Med Chem Lett 17: 4415-8 (2007)
- Hrib, NJ; Jurcak, JG; Bregna, DE; Burgher, KL; Hartman, HB; Kafka, S; Kerman, LL; Kongsamut, S; Roehr, JE; Szewczak, MR; Woods-Kettelberger, AT; Corbett, R J Med Chem 39: 4044-57 (1996)
- Frølund, B; Jørgensen, AT; Tagmose, L; Stensbøl, TB; Vestergaard, HT; Engblom, C; Kristiansen, U; Sanchez, C; Krogsgaard-Larsen, P; Liljefors, T J Med Chem 45: 2454-68 (2002)
- ChEMBL_1871101 (CHEMBL4372268) Inhibition of human CYP3A4 using atorvastatin as substrate
- ChEMBL_689765 (CHEMBL1635605) Inhibition of CYP3A4 in human liver microsomes using atorvastatin as probe
- ChEMBL_1687642 (CHEMBL4038121) Inhibition of atorvastatin PEG-fluorescein binding to PDEdelta (unknown origin) by fluorescence polarization assay
- ChEMBL_2476088 Displacement of fluorescein-labeled Atorvastatin from PDEdelta (unknown origin) assessed as dissociation constant incubated for 10 hrs by fluorescence anisotropy
- ChEMBL_1889156 (CHEMBL4390910) Inhibition of CYP3A4 in human liver microsomes using atorvastatin as substrate preincubated for 7 mins followed by NADPH addition and measured by LC-MS/MS analysis
- ChEMBL_1493572 (CHEMBL3529386) Inhibition of CYP3A4 in human liver microsomes using atorvastatin as substrate preincubated for 20 mins with substrate prior to initiation of reaction with NADPH by HPLC analysis
- ChEMBL_2476030 Displacement of fluorescein-labeled Atorvastatin from N-terminal His6 tagged human recombinant PDE6D extracted from Escherichia coli BL21 star (DE3) pLysS assessed as dissociation constant by fluorescence polarization assay
- ChEMBL_1493640 (CHEMBL3530056) Metabolism-dependent inhibition of CYP3A4 in human liver microsomes using atorvastatin as substrate preincubated for 20 mins with NADPH prior to initiation of reaction with probe substrate by HPLC analysis
- ChEMBL_302165 (CHEMBL829233) Dissociation constant for [3H]ORG2058 at human progesterone receptor at 293K
- ChEMBL_302168 (CHEMBL875181) Dissociation constant for [3H]-ORG2058 at human progesterone receptor at 310K
- ChEMBL_378649 (CHEMBL853470) Inhibition at CYP2C9
- ChEMBL_425011 (CHEMBL912532) Activity at PPARdelta
- ChEMBL_579846 (CHEMBL1062385) Activity at PXR
- ChEMBL_590791 (CHEMBL1037629) Activity at PPARalpha
- ChEMBL_302134 (CHEMBL841758) Dissociation constant for [3H]ORG2058 at human progesterone receptor at 303 K
- ChEMBL_302161 (CHEMBL829229) Dissociation constant for [3H]ORG2058 at human progesterone receptor at 273 K
- ChEMBL_302162 (CHEMBL829230) Dissociation constant for [3H]-ORG2058 at human progesterone receptor at 278 K
- ChEMBL_302163 (CHEMBL829231) Dissociation constant for [3H]-ORG2058 at human progesterone receptor at 283 K
- ChEMBL_302164 (CHEMBL829232) Dissociation constant for [3H]ORG2058 at human progesterone receptor at 288 K
- ChEMBL_302166 (CHEMBL829234) Dissociation constant for [3H]ORG2058 at human progesterone receptor at 298 K
- ChEMBL_302167 (CHEMBL829235) Dissociation constant for [3H]ORG2058 at human progesterone receptor at 308 K
- ChEMBL_320800 (CHEMBL884755) Inhibitory activity against Mandelate racemase at pH 6.3 at 25 degree C
- ChEMBL_320801 (CHEMBL884756) Inhibitory activity against Mandelate racemase at pH 7.5 at 25 degree C
- ChEMBL_320802 (CHEMBL884757) Inhibitory activity against Mandelate racemase at pH 8.7 at 25 degree C
- ChEMBL_1458552 (CHEMBL3370870) Inhibition of xanthine oxidase (unknown origin) at 37 degC at ph 7..8
- ChEBML_158177 Affinity at human EP1 receptor.
- ChEBML_158303 Affinity at human EP2 receptor.
- ChEBML_158320 Affinity at human EP3 receptor.
- ChEBML_158335 Affinity at human EP4 receptor.
- ChEBML_1679920 Activity at human M1 receptor
- ChEBML_1679921 Activity at human M2 receptor
- ChEBML_1679922 Activity at human M3 receptor
- ChEBML_1679923 Activity at human M5 receptor
- ChEBML_1679924 Activity at rat M1 receptor
- ChEBML_1679925 Activity at rat M2 receptor
- ChEBML_1679926 Activity at rat M3 receptor
- ChEBML_1679927 Activity at rat M5 receptor
- ChEBML_1682489 Agonist activity at human TGR5
- ChEBML_1682491 Agonist activity at mouse TGR5
- ChEBML_1684415 Agonist activity at mouse GPR52
- ChEBML_1707951 Antagonist activity at mouse CXCR4
- ChEMBL_1648281 (CHEMBL3997337) Activity at human PXR
- ChEMBL_2267947 Agonist activity at human TLR7
- ChEMBL_2268534 Agonist activity at human FXR
- ChEMBL_2273235 Agonist activity at human TAAR1
- ChEMBL_2274190 Agonist activity at human TLR8
- ChEMBL_2275379 Agonist activity at human D4R
- ChEMBL_2275504 Antagonist activity at human mGlur2
- ChEMBL_2276094 Agonist activity at human FXR
- ChEMBL_2281197 Agonist activity at mouse STING
- ChEMBL_2286906 Antagonist activity at rat TRPV1
- ChEMBL_2287251 Agonist activity at mouse TGR5
- ChEMBL_2287252 Agonist activity at human TGR5
- ChEMBL_2296943 Agonist activity at human P2Y1
- ChEMBL_2296961 Agonist activity at human P2Y2
- ChEMBL_2296963 Antagonist activity at mouse P2Y2
- ChEMBL_2296967 Antagonist activity at human P2Y4
- ChEMBL_2296968 Antagonist activity at rat P2Y4
- ChEMBL_2296972 Antagonist activity at human P2Y6
- ChEMBL_2296977 Antagonist activity at human P2Y12
- ChEMBL_2296983 Antagonist activity at rat P2Y14
- ChEMBL_2303321 Agonist activity at human RORgammat
- ChEMBL_2304136 Agonist activity at mouse PPARalpha
- ChEMBL_2304137 Agonist activity at human PPARalpha
- ChEMBL_2304145 Agonist activity at human PPARdelta
- ChEMBL_2304146 Agonist activity at human PPARgamma
- ChEMBL_2331723 Agonist activity at human TLR3
- ChEMBL_2331724 Agonist activity at human TLR8
- ChEMBL_2331725 Agonist activity at human TLR9
- ChEMBL_2331733 Antagonist activity at human TLR8
- ChEMBL_2331741 Agonist activity at human TLR7
- ChEMBL_2337239 Antagonist activity at human TRPV4
- ChEMBL_2349299 Agonist activity at human TLR8
- ChEMBL_2349325 Agonist activity at mouse TLR7
- ChEMBL_2349468 Agonist activity at mouse TLR7
- ChEMBL_2349473 Agonist activity at human TLR8
- ChEMBL_2354444 Activity at PXR (unknown origin)
- ChEMBL_2354445 Activity at PDE4 (unknown origin)
- ChEMBL_2363357 Antagonist activity at human CMKLR1
- ChEMBL_2376399 Agonist activity at human FXR
- ChEMBL_2438651 Antagonist activity at human TRPV1
- ChEMBL_2443909 Agonist activity at mouse FPR2
- ChEMBL_2473139 Antagonist activity at human TRPA1
- ChEMBL_2493626 Agonist activity at human PPARgamma
- ChEMBL_390600 (CHEMBL870982) Binding affinity at alpha4beta2
- ChEMBL_425900 (CHEMBL907960) Activity at CRTH2 receptor
- ChEMBL_432854 (CHEMBL915603) Binding affinity at NET
- ChEMBL_437679 (CHEMBL905954) Inhibition at human CYP2D6
- ChEMBL_439660 (CHEMBL888775) Binding affinity at mGluR1
- ChEMBL_439661 (CHEMBL888776) Binding affinity at mGluR2
- ChEMBL_439662 (CHEMBL888777) Binding affinity at mGluR4
- ChEMBL_439663 (CHEMBL888778) Binding affinity at mGluR6
- ChEMBL_439664 (CHEMBL888779) Binding affinity at mGluR8
- ChEMBL_443413 (CHEMBL893666) Binding Affinity at CCL3
- ChEMBL_447643 (CHEMBL896650) Binding affinity at PR
- ChEMBL_447644 (CHEMBL896651) Binding affinity at AR
- ChEMBL_447645 (CHEMBL896652) Binding affinity at MR
- ChEMBL_448548 (CHEMBL897698) Antagonist activity at MCHR1
- ChEMBL_452234 (CHEMBL901386) Agonist activity at GHSR
- ChEMBL_458140 (CHEMBL925473) Binding affinity at AR
- ChEMBL_461897 (CHEMBL929033) Agonist activity at MC4R
- ChEMBL_461898 (CHEMBL929034) Binding affinity at MC4R
- ChEMBL_465724 (CHEMBL932290) Binding affinity at PPARgamma
- ChEMBL_469445 (CHEMBL946803) Binding affinity at FGF1
- ChEMBL_471807 (CHEMBL940091) Activity at RNase A
- ChEMBL_473613 (CHEMBL939381) Binding affinity at MLCK
- ChEMBL_477747 (CHEMBL939957) Inhibition of GABA-AT
- ChEMBL_490865 (CHEMBL993604) Activity at 5HT2A receptor
- ChEMBL_490866 (CHEMBL989142) Activity at 5HT2B receptor
- ChEMBL_490867 (CHEMBL989143) Activity at 5HT2C receptor
- ChEMBL_501595 (CHEMBL987724) Antagonist activity at mGluR1
- ChEMBL_501603 (CHEMBL987732) Antagonist activity at mGluR5
- ChEMBL_501617 (CHEMBL993707) Antagonist activity at MCH1R
- ChEMBL_519599 (CHEMBL943674) Agonist activity at GPR40
- ChEMBL_531313 (CHEMBL989725) Activity at CB2 receptor
- ChEMBL_535176 (CHEMBL988115) Agonist activity at GHSR
- ChEMBL_536825 (CHEMBL988089) Binding affinity at GPR109a
- ChEMBL_539581 (CHEMBL1035756) Agonist activity at PPARalpha
- ChEMBL_552643 (CHEMBL959734) Binding affinity at DAT
- ChEMBL_555613 (CHEMBL965660) Antagonist activity at MC4R
- ChEMBL_555732 (CHEMBL959088) Binding affinity at SERT
- ChEMBL_555733 (CHEMBL959089) Binding affinity at NET
- ChEMBL_598674 (CHEMBL1050755) Agonist activity at GIPR
- ChEMBL_598678 (CHEMBL1050759) Agonist activity at PTHR
- ChEMBL_605056 (CHEMBL1071918) Agonist activity at mGluR1
- ChEMBL_605057 (CHEMBL1071919) Antagonist activity at mGluR1
- ChEMBL_605058 (CHEMBL1071920) Agonist activity at mGluR5
- ChEMBL_605059 (CHEMBL1071921) Antagonist activity at mGluR5
- ChEMBL_609753 (CHEMBL1069371) Agonist activity at NET
- ChEMBL_609754 (CHEMBL1069372) Agonist activity at DAT
- ChEMBL_609755 (CHEMBL1069373) Agonist activity at SERT
- ChEMBL_615462 (CHEMBL1107780) Antagonistic activity at TGFBR1
- ChEMBL_620941 (CHEMBL1117586) Antagonist activity at mGluR5
- ChEMBL_625709 (CHEMBL1103539) Agonist activity at TLR8
- ChEMBL_628657 (CHEMBL1106423) Antagonist activity at 5HT1A
- ChEMBL_640125 (CHEMBL1174525) Antagonist activity at CCR4
- ChEMBL_640126 (CHEMBL1174526) Antagonist activity at CCR5
- ChEMBL_660467 (CHEMBL1250097) Agonist activity at FXR
- ChEMBL_674528 (CHEMBL1274439) Agonist activity at RARalpha
- ChEMBL_674529 (CHEMBL1274440) Agonist activity at RARbeta
- ChEMBL_674530 (CHEMBL1274441) Agonist activity at RARgamma
- ChEMBL_695416 (CHEMBL1639086) Antagonist activity at mGluR5
- ChEMBL_701161 (CHEMBL1648781) Activity at human PXR
- ChEMBL_740553 (CHEMBL1764754) Agonist activity at PXR
- ChEMBL_744776 (CHEMBL1772797) Antagonist activity at FPR1
- ChEMBL_749292 (CHEMBL1785227) Agonist activity at PPARgamma
- ChEMBL_750608 (CHEMBL1785454) Agonist activity at PPARalpha
- ChEMBL_756379 (CHEMBL1805405) Agonist activity at GPR109a
- ChEMBL_772828 (CHEMBL1837700) Agonist activity at TLR7
- ChEMBL_785832 (CHEMBL1921048) Antagonist activity at AR
- ChEMBL_786503 (CHEMBL1921084) Agonist activity at FXR
- ChEMBL_791051 (CHEMBL1925761) Antagonist activity at CCR1
- ChEMBL_791052 (CHEMBL1925762) Antagonist activity at CCR4
- ChEMBL_793710 (CHEMBL1932524) Agonist activity at TRPV1
- ChEMBL_807172 (CHEMBL1959836) Antagonist activity at CXCR4
- ChEMBL_815240 (CHEMBL2025431) Agonist activity at TLR7
- ChEMBL_816615 (CHEMBL2025329) Agonist activity at MT1
- ChEMBL_821151 (CHEMBL2039693) Antagonist activity at VEGFR2
- ChEMBL_822292 (CHEMBL2038446) Agonist activity at PPARalpha
- ChEMBL_822293 (CHEMBL2038596) Agonist activity at PPARdelta
- ChEMBL_822294 (CHEMBL2038597) Agonist activity at PPARgamma
- ChEMBL_834190 (CHEMBL2072930) Agonist activity at PPARalpha
- ChEMBL_849493 (CHEMBL2149600) Activity at 5HT1A receptor
- ChEMBL_854780 (CHEMBL2161911) Agonist activity at FXR
- ChEMBL_861587 (CHEMBL2174528) Antagonist activity at MOR
- ChEMBL_861588 (CHEMBL2174529) Antagonist activity at DOR
- ChEMBL_862589 (CHEMBL2173985) Agonist activity at GPR119
- ChEMBL_875636 (CHEMBL2184867) Antagonist activity at CCR1
- ChEMBL_879201 (CHEMBL2208514) Antagonist activity at CHT1
- ChEMBL_879208 (CHEMBL2208521) Antagonist activity at CXCR4
- ChEMBL_884620 (CHEMBL2214167) Inactivation of GABA-AT
- ChEMBL_887246 (CHEMBL2215802) Antagonist activity at CCR1
- ChEMBL_887603 (CHEMBL2217212) Antagonist activity at CCR4
- ChEMBL_100385 (CHEMBL708677) Evaluated for Functional Activity at MC3R as effective concentration at 50% maximum CMP accumulation
- ChEMBL_100392 (CHEMBL708684) Evaluated for Functional Activity at MC5R as effective concentration at 50% maximum CMP accumulation
- ChEMBL_159633 (CHEMBL763424) Inhibitory concentration against HIV-1 Protease at pH 5.6 and at 37 degrees C
- Enzyme Assay The enzyme were assayed spectrophotometrically at 410nm with p-nitroanilide substrates at 25 C.
- ChEMBL_1931016 (CHEMBL4434267) Agonist activity at human Kv7.2/Kv7.3 expressed in CHO cells at holding potential of at -85 mV by whole cell patch clamp electrophysiology assay
- ChEMBL_31776 (CHEMBL643102) Inhibitory activity against human placental aldose reductase in Orange A column at at day 2
- ChEMBL_31777 (CHEMBL643103) Inhibitory activity against human placental aldose reductase in Orange A column at at time 2
- ChEMBL_614789 (CHEMBL1113308) Agonistic activity at rat BRS3 expressed in HEK293AEO at 10 uM by aequorin bioluminescence assay
- ChEMBL_718092 (CHEMBL1671545) Agonist activity at human mGluR2 expressed in CHO cells at by [S35]GTPgammaS binding assay
- ChEMBL_789869 (CHEMBL1925176) Positive allosteric modulator activity at human mGlu6 receptor at 10 uM by thallium flux assay
- ChEMBL_789871 (CHEMBL1925178) Positive allosteric modulator activity at rat mGlu7 receptor at 10 uM by thallium flux assay
- ChEMBL_853041 (CHEMBL2154388) Antagonist activity at Cav3.3 at -100 mV holding potential by whole cell patch clamp analysis
- ChEMBL_853042 (CHEMBL2154389) Antagonist activity at Cav3.3 at -80 mV holding potential by whole cell patch clamp analysis
- ChEBML_1572015 Agonist activity at FXR (unknown origin)
- ChEBML_1647937 Agonist activity at mouse FFA4 receptor
- ChEBML_1647938 Agonist activity at rat FFA4 receptor
- ChEBML_1647940 Agonist activity at mouse FFA1 receptor
- ChEBML_1647942 Agonist activity at rat FFA1 receptor
- ChEBML_1648049 Antagonist activity at human IP receptor
- ChEBML_1648059 Antagonist activity at human EP1 receptor
- ChEBML_1648060 Antagonist activity at human EP2 receptor
- ChEBML_1648061 Antagonist activity at human EP3 receptor
- ChEBML_1648064 Antagonist activity at human FP receptor
- ChEBML_1686618 Agonist activity at RXRaplha (unknown origin)
- ChEBML_1686619 Agonist activity at RXRbeta (unknown origin)
- ChEBML_1686620 Agonist activity at RXRgamma (unknown origin)
- ChEBML_1686646 Agonist activity at RARaplha (unknown origin)
- ChEBML_1686647 Agonist activity at RARbeta (unknown origin)
- ChEBML_1686648 Agonist activity at RARgamma (unknown origin)
- ChEBML_1687080 Agonist activity at CCR10 (unknown origin)
- ChEBML_1687081 Agonist activity at CCR2 (unknown origin)
- ChEBML_1687084 Agonist activity at CCR5 (unknown origin)
- ChEBML_1687095 Agonist activity at CXCR5 (unknown origin)
- ChEBML_1687103 Antagonist activity at CCR6 (unknown origin)
- ChEBML_1687104 Antagonist activity at CCR7 (unknown origin)
- ChEBML_1687105 Antagonist activity at CCR8 (unknown origin)
- ChEBML_1687106 Antagonist activity at CCR9 (unknown origin)
- ChEBML_1687108 Antagonist activity at CX3CR1 (unknown origin)
- ChEBML_1687110 Antagonist activity at CXCR3 (unknown origin)
- ChEBML_1687111 Antagonist activity at CXCR4 (unknown origin)
- ChEBML_1687114 Antagonist activity at CXCR7 (unknown origin)
- ChEMBL_1275520 (CHEMBL3090535) Agonist activity at human PXR
- ChEMBL_1365355 (CHEMBL3292679) Agonist activity at human TGR5
- ChEMBL_1367589 Agonist activity at GPR52 (unknown origin)
- ChEMBL_1438933 (CHEMBL3382444) Agonist activity at human GPR119
- ChEMBL_1441405 (CHEMBL3373360) Agonist activity at rat NK3R
- ChEMBL_1458014 (CHEMBL3367188) Activity at RARalpha (unknown origin)
- ChEMBL_1458015 (CHEMBL3367189) Activity at RARbeta (unknown origin)
- ChEMBL_1458016 (CHEMBL3367190) Activity at RARgamma (unknown origin)
- ChEMBL_1458017 (CHEMBL3367191) Activity at RXRalpha (unknown origin)
- ChEMBL_1458369 (CHEMBL3369562) Agonist activity at human PPARgamma
- ChEMBL_1502758 (CHEMBL3591009) Antagonist activity at rat MCHR1
- ChEMBL_1506470 (CHEMBL3599869) Antagonist activity at human CysLT1
- ChEMBL_1525545 (CHEMBL3637052) Antagonist activity at human 5HT2b
- ChEMBL_1631220 (CHEMBL3873926) Activity at human 5HT1A receptor
- ChEMBL_1631221 (CHEMBL3873927) Activity at human 5HT1B receptor
- ChEMBL_1631222 (CHEMBL3873928) Activity at human 5HT1D receptor
- ChEMBL_1631223 (CHEMBL3873929) Activity at human 5HT1E receptor
- ChEMBL_1631224 (CHEMBL3873930) Activity at human 5HT1F receptor
- ChEMBL_1631225 (CHEMBL3873931) Activity at human 5HT2A receptor
- ChEMBL_1631226 (CHEMBL3873932) Activity at human 5T2B receptor
- ChEMBL_1631227 (CHEMBL3873933) Activity at human 5T2C receptor
- ChEMBL_1701231 (CHEMBL4052213) Agonist activity at mouse MC3R
- ChEMBL_1701232 (CHEMBL4052214) Agonist activity at mouse MC4R
- ChEMBL_1703432 (CHEMBL4054665) Antagonist activity at human P2X7
- ChEMBL_1719304 (CHEMBL4134304) Antagonist activity at mouse CCR4
- ChEMBL_1719317 (CHEMBL4134317) Antagonist activity at dog CCR4
- ChEMBL_1729696 (CHEMBL4144974) Activation at PXR (unknown origin)
- ChEMBL_1738581 (CHEMBL4154331) Agonist activity at rat GPR40
- ChEMBL_1738582 (CHEMBL4154332) Agonist activity at mouse GPR40
- ChEMBL_1754035 (CHEMBL4188795) Agonist activity at human GPR40
- ChEMBL_1754037 (CHEMBL4188797) Agonist activity at mouse GPR40
- ChEMBL_1776558 (CHEMBL4233550) Agonist activity at human GPR120
- ChEMBL_1797287 (CHEMBL4269404) Agonist activity at human NLRP3
- ChEMBL_1809570 (CHEMBL4309030) Antagonist activity at human PAR2
- ChEMBL_1809571 (CHEMBL4309031) Antagonist activity at human PAR1
- ChEMBL_1809572 (CHEMBL4309032) Antagonist activity at human PAR4
- ChEMBL_1823196 (CHEMBL4322960) Antagonist activity at human TRPV4
- ChEMBL_1832094 (CHEMBL4332102) Agonist activity at human PPARgamma
- ChEMBL_1832153 (CHEMBL4332161) Antagonist activity at mouse PPARalpha
- ChEMBL_1832154 (CHEMBL4332162) Antagonist activity at mouse PPARdelta
- ChEMBL_1832155 (CHEMBL4332163) Antagonist activity at mouse PPARgamma
- ChEMBL_1832187 (CHEMBL4332195) Agonist activity at human PPARalpha
- ChEMBL_1832188 (CHEMBL4332196) Agonist activity at human PPARdelta
- ChEMBL_1832189 (CHEMBL4332197) Antagonist activity at human PPARalpha
- ChEMBL_1832255 (CHEMBL4332263) Agonist activity at rat KISS1R
- ChEMBL_1837345 (CHEMBL4337478) Agonist activity at human MrgprX1
- ChEMBL_1837347 (CHEMBL4337480) Agonist activity at rat MRGPRC
- ChEMBL_1837348 (CHEMBL4337481) Agonist activity at mouse MRGPRC11
- ChEMBL_1837936 (CHEMBL4338069) Activity at PXR (unknown origin)
- ChEMBL_1837937 (CHEMBL4338070) Activity at RORalpha (unknown origin)
- ChEMBL_1837938 (CHEMBL4338071) Activity at RORbeta (unknown origin)
- ChEMBL_1837939 (CHEMBL4338072) Activity at LXRalpha (unknown origin)
- ChEMBL_1837940 (CHEMBL4338073) Activity at LXRbeta (unknown origin)
- ChEMBL_1909079 (CHEMBL4411525) Agonist activity at human TRPA1
- ChEMBL_1978135 (CHEMBL4611270) Antagonist activity at human CCR6
- ChEMBL_1978136 (CHEMBL4611271) Antagonist activity at human CXCR5
- ChEMBL_1978137 (CHEMBL4611272) Antagonist activity at human CXCR4
- ChEMBL_1989313 (CHEMBL4623048) Agonist activity at human GPR119
- ChEMBL_1991080 (CHEMBL4624815) Agonist activity at human PPARdelta
- ChEMBL_1994275 (CHEMBL4628170) Agonist activity at mouse TRPV4
- ChEMBL_1994277 (CHEMBL4628172) Antagonist activity at human TRPV4
- ChEMBL_2016278 (CHEMBL4669856) Agonist activity at human SST4
- ChEMBL_2016279 (CHEMBL4669857) Agonist activity at human SST5
- ChEMBL_2016280 (CHEMBL4669858) Agonist activity at human SST1
- ChEMBL_2016281 (CHEMBL4669859) Agonist activity at human SST3
- ChEMBL_2026871 (CHEMBL4681029) Agonist activity at human CAR
- ChEMBL_2026876 (CHEMBL4681034) Agonist activity at human PXR
- ChEMBL_2026879 (CHEMBL4681037) Agonist activity at human VDR
- ChEMBL_2026880 (CHEMBL4681038) Agonist activity at human ER
- ChEMBL_2026881 (CHEMBL4681039) Agonist activity at human PR
- ChEMBL_2026882 (CHEMBL4681040) Agonist activity at human TR
- ChEMBL_2026883 (CHEMBL4681041) Agonist activity at human GR
- ChEMBL_2064212 (CHEMBL4719465) Agonist activity at mouse TAAR1
- ChEMBL_2066652 (CHEMBL4721905) Modulator activity at mouse PPARdelta
- ChEMBL_2071467 (CHEMBL4727001) Antagonist activity at human TRPV4
- ChEMBL_2071468 (CHEMBL4727002) Antagonist activity at mouse TRPV4
- ChEMBL_2071469 (CHEMBL4727003) Antagonist activity at rat TRPV4
- ChEMBL_2091001 (CHEMBL4772264) Agonist activity at rat NPFFR1
- ChEMBL_2091002 (CHEMBL4772265) Agonist activity at rat NPFFR2
- ChEMBL_2102316 (CHEMBL4810712) Antagonist activity at human ERG
- ChEMBL_2118955 (CHEMBL4828021) Antagonist activity at rat TRPA1
- ChEMBL_2119374 (CHEMBL4828440) Antagonist activity at human TRPV4
- ChEMBL_2130313 (CHEMBL4839742) Antagonist activity at mouse CaSR
- ChEMBL_2132067 (CHEMBL4841582) Agonist activity at human SSTR2
- ChEMBL_2148831 (CHEMBL5033229) Activity at PPARgamma (unknown origin)
- ChEMBL_215023 (CHEMBL856234) Antidiuretic activity at V2 receptor
- ChEMBL_215024 (CHEMBL820875) Antidiuretic activity at V2 receptor
- ChEMBL_2192403 (CHEMBL5104763) Agonist activity at human 5HT2b
- ChEMBL_2203297 (CHEMBL5116005) Agonist activity at human SST1
- ChEMBL_2203298 (CHEMBL5116006) Agonist activity at human SST2
- ChEMBL_2203299 (CHEMBL5116007) Agonist activity at human SST3
- ChEMBL_2203300 (CHEMBL5116008) Agonist activity at human SST4
- ChEMBL_2203301 (CHEMBL5116009) Agonist activity at rat SST5
- ChEMBL_2203822 (CHEMBL5116530) Agonist activity at mouse STING
- ChEMBL_2203826 (CHEMBL5116534) Agonist activity at human STING
- ChEMBL_2208398 (CHEMBL5121347) Agonist activity at human PPARgamma
- ChEMBL_2208431 (CHEMBL5121380) Agonist activity at mouse LXRbeta
- ChEMBL_2208452 (CHEMBL5121401) Agonist activity at human GPR119
- ChEMBL_2239361 (CHEMBL5153257) Agonist activity at human TRPV1
- ChEMBL_2239364 (CHEMBL5153260) Agonist activity at human TRPV4
- ChEMBL_2263482 Antagonist activity at CXCR1 (unknown origin)
- ChEMBL_2263483 Antagonist activity at CXCR2 (unknown origin)
- ChEMBL_2266636 Agonist activity at TLR2 (unknown origin)
- ChEMBL_2267540 Agonist activity at GPR40 (unknown origin)
- ChEMBL_2267541 Agonist activity at GPR120 (unknown origin)
- ChEMBL_2268355 Agonist activity at RXRalpha (unknown origin)
- ChEMBL_2268356 Agonist activity at RXRbeta (unknown origin)
- ChEMBL_2268357 Agonist activity at RXRgamma (unknown origin)
- ChEMBL_2268363 Antagonist activity at RXRalpha (unknown origin)
- ChEMBL_2268533 Antagonist activity at H3R (unknown origin)
- ChEMBL_2268537 Agonist activity at VDR (unknown origin)
- ChEMBL_2269351 Antagonist activity at human LRH-1
- ChEMBL_2271750 Antagonist activity at CCR2 (unknown origin)
- ChEMBL_2273237 Agonist activity at 5HT1A (unknown origin)
- ChEMBL_2274184 Agonist activity at TLR8 (unknown origin)
- ChEMBL_2275386 Agonist activity at D4R (unknown origin)
- ChEMBL_2275387 Agonist activity at D3R (unknown origin)
- ChEMBL_2276112 Agonist activity at FXR (unknown origin)
- ChEMBL_2280117 Agonist activity at FFAR1 (unknown origin)
- ChEMBL_2281191 Agonist activity at human TLR7 receptor
- ChEMBL_2281192 Agonist activity at human TLR8 receptor
- ChEMBL_2281510 Agonist activity at PPARgamma (unknown origin)
- ChEMBL_2281515 Agonist activity at PPARalpha (unknown origin)
- ChEMBL_2281517 Agonist activity at PPARdelta (unknown origin)
- ChEMBL_2281519 Antagonist activity at PPARgamma (unknown origin)
- ChEMBL_2281723 Antagonist activity at human LPA3 receptor
- ChEMBL_2281726 Antagonist activity at human LPA1 receptor
- ChEMBL_2282480 Agonist activity at EP3 (unknown origin)
- ChEMBL_2283680 Antagonist activity at OX1R (unknown origin)
- ChEMBL_2283681 Antagonist activity at OX2R (unknown origin)
- ChEMBL_2283982 Agonist activity at TLR8 (unknown origin)
- ChEMBL_2283990 Agonist activity at TLR7 (unknown origin)
- ChEMBL_2286910 Antagonist activity at mGluR1alpha (unknown origin)
- ChEMBL_2287219 Agonist activity at TGR5 (unknown origin)
- ChEMBL_2287261 Agonist activity at FXR (unknown origin)
- ChEMBL_2287269 Antagonist activity at FXR (unknown origin)
- ChEMBL_2289549 Agonist activity at AhR (unknown origin)
- ChEMBL_2289558 Antagonist activity at AhR (unknown origin)
- ChEMBL_2289559 Modulator activity at AhR (unknown origin)
- ChEMBL_2292792 Agonist activity at human recombinant TRPM8
- ChEMBL_2292793 Agonist activity at TRPM8 (unknown origin)
- ChEMBL_2292794 Agonist activity at TRPA1 (unknown origin)
- ChEMBL_2292808 Antagonist activity at TRPM8 (unknown origin)
- ChEMBL_2296940 Antagonist activity at pA2 (unknown origin)
- ChEMBL_2300277 Antagonist activity at human CCR5 receptor
- ChEMBL_2303320 Inverse agonist activity at human RORgammat
- ChEMBL_2304135 Agonist activity at FXR (unknown origin)
- ChEMBL_2304138 Agonist activity at PPARalpha (unknown origin)
- ChEMBL_2304140 Agonist activity at PPARgamma (unknown origin)
- ChEMBL_2304148 Antagonist activity at CCR2 (unknown origin)
- ChEMBL_2304149 Antagonist activity at CCR5 (unknown origin)
- ChEMBL_2304157 Agonist activity at PPARdelta (unknown origin)
- ChEMBL_2321788 Inverse agonist activity at human H3R
- ChEMBL_2323057 Agonist activity at RORgammat (unknown origin)
- ChEMBL_2325407 Antagonist activity at PR (unknown origin)
- ChEMBL_2325408 Antagonist activity at GR (unknown origin)
- ChEMBL_2325409 Antagonist activity at ERbeta (unknown origin)
- ChEMBL_2325410 Antagonist activity at ERalpha (unknown origin)
- ChEMBL_2329463 Inhibition of hERG at 10 uM
- ChEMBL_2331719 Agonist activity at TLR8 (unknown origin)
- ChEMBL_2331720 Agonist activity at TLR7 (unknown origin)
- ChEMBL_2331722 Antagonist activity at TLR3 (unknown origin)
- ChEMBL_2331731 Antagonist activity at TLR5 (unknown origin)
- ChEMBL_2331736 Antagonist activity at human TLR1/TLR2
- ChEMBL_2331737 Antagonist activity at human TLR2/TLR6
- ChEMBL_2346685 Agonist activity at PPARalpha (unknown origin)
- ChEMBL_2346686 Agonist activity at PPARdelta (unknown origin)
- ChEMBL_2346687 Agonist activity at PPARgamma (unknown origin)
- ChEMBL_2349902 Agonist activity at MOR (unknown origin)
- ChEMBL_2350514 Antagonist activity at human P2X7 receptor
- ChEMBL_2353985 Antagonist activity at human P2X7 receptor
- ChEMBL_2353986 Antagonist activity at mouse P2X7 receptor
- ChEMBL_2353987 Antagonist activity at rat P2X7 receptor
- ChEMBL_2354067 Agonist activity at PXR (unknown origin)
- ChEMBL_2370544 Antagonist activity at CK2 (unknown origin)
- ChEMBL_2371684 Antagonist activity at rat adrenergic alpha2B
- ChEMBL_2371685 Antagonist activity at dog adrenergic alpha2B
- ChEMBL_2373625 Antagonist activity at P2Y6R (unknown origin)
- ChEMBL_2375092 Antagonist activity at TRPV1 (unknown origin)
- ChEMBL_2375100 Antagonist activity at human recombinant TPRV1
- ChEMBL_2376400 Agonist activity at FXR (unknown origin)
- ChEMBL_2376877 Antagonist activity at PAR2 (unknown origin)
- ChEMBL_2422156 Agonist activity at human PPAR gamma
- ChEMBL_2426870 Agonist activity at PARG (unknown origin)
- ChEMBL_2434034 Antagonist activity at P2X7R (unknown origin)
- ChEMBL_2434314 Agonist activity at AMPK (unknown origin)
- ChEMBL_2434874 Antagonist activity at TLR7 (unknown origin)
- ChEMBL_2437613 Agonist activity at TLR7 (unknown origin)
- ChEMBL_2460914 Antagonist activity at human P2X7 receptor
- ChEMBL_2468400 Agonist activity at NOD2 (unknown origin)
- ChEMBL_2471576 Antagonist activity at human P2X3 receptor
- ChEMBL_2476285 Antagonist activity at NUDT5 (unknown origin)
- ChEMBL_2479556 Antagonist activity at TRPC5 (unknown origin)
- ChEMBL_2483562 Agonist activity at FXR (unknown origin)
- ChEMBL_2491257 Antagonist activity at PPARgamma (unknown origin)
- ChEMBL_2492830 Agonist activity at TRPA1 (unknown origin)
- ChEMBL_2503692 Agonist activity at STING (unknown origin)
- ChEMBL_2543753 Antagonist activity at TRPA1 (unknown origin)
- ChEMBL_2543760 Antagonist activity at TRPV1 (unknown origin)
- ChEMBL_329053 (CHEMBL863299) Functional activity at rat mGluR4
- ChEMBL_339212 (CHEMBL866559) Agonist potency at MC4 receptor
- ChEMBL_376272 (CHEMBL854481) Activity at human PPAR alpha
- ChEMBL_378648 (CHEMBL853469) Inhibition at recombinant human CYP2C19
- ChEMBL_378650 (CHEMBL853471) Inhibition at rat aldose reductase
- ChEMBL_378651 (CHEMBL853472) Inhibition at rat serotonin transporter
- ChEMBL_389723 (CHEMBL868030) Agonist activity at human H2R
- ChEMBL_391339 (CHEMBL870475) Binding affinity at 5HT2A receptor
- ChEMBL_395993 (CHEMBL910338) Agonist activity at human MC1R
- ChEMBL_395995 (CHEMBL910340) Agonist activity at human MC3R
- ChEMBL_395997 (CHEMBL910342) Agonist activity at human MC4R
- ChEMBL_438312 (CHEMBL887414) Agonist activity at human AR
- ChEMBL_440117 (CHEMBL890429) Antagonist activity at human GR
- ChEMBL_440538 (CHEMBL889637) Agonist activity at human CB2R
- ChEMBL_444184 (CHEMBL892292) Binding affinity at mouse CCR1
- ChEMBL_444185 (CHEMBL892293) Binding affinity at rat CCR1
- ChEMBL_448111 (CHEMBL898367) Agonist activity at ghrelin receptor
- ChEMBL_449235 (CHEMBL899497) Binding affinity at human PR
- ChEMBL_449278 (CHEMBL899540) Binding affinity at rat SERT
- ChEMBL_449279 (CHEMBL899541) Binding affinity at human SERT
- ChEMBL_449484 (CHEMBL899759) Binding affinity at human MC4R
- ChEMBL_449488 (CHEMBL899755) Binding affinity at human MC3R
- ChEMBL_449489 (CHEMBL899753) Binding affinity at mouse MC3R
- ChEMBL_449490 (CHEMBL899752) Binding affinity at rat MC3R
- ChEMBL_449491 (CHEMBL899750) Binding affinity at mouse MC4R
- ChEMBL_449492 (CHEMBL899760) Binding affinity at rat MC4R
- ChEMBL_449493 (CHEMBL899761) Binding affinity at human MC5R
- ChEMBL_449509 (CHEMBL899776) Agonist activity at ghrelin receptor
- ChEMBL_450524 (CHEMBL900815) Binding affinity at mouse MC4R
- ChEMBL_451555 (CHEMBL901765) Activity at vasopressin V1A receptor
- ChEMBL_451950 (CHEMBL901108) Binding affinity at CB1 receptor
- ChEMBL_453432 (CHEMBL885431) Binding affinity at rat SERT
- ChEMBL_453433 (CHEMBL885432) Binding affinity at human SERT
- ChEMBL_454342 (CHEMBL903520) Binding affinity at CB1 receptor
- ChEMBL_454343 (CHEMBL903521) Binding affinity at CB2 receptor
- ChEMBL_455313 (CHEMBL886089) Binding affinity at rat SERT
- ChEMBL_455314 (CHEMBL886090) Binding affinity at human SERT
- ChEMBL_458156 (CHEMBL924413) Binding affinity at 5HT2A receptor
- ChEMBL_458618 (CHEMBL941947) Binding affinity at 5HT1B receptor
- ChEMBL_461136 (CHEMBL944159) Binding affinity at 5HT7 receptor
- ChEMBL_461175 (CHEMBL945120) Antagonist activity at mGlu1 receptor
- ChEMBL_461176 (CHEMBL945121) Agonist activity at mGlu2 receptor
- ChEMBL_461177 (CHEMBL945122) Antagonist activity at mGlu2 receptor
- ChEMBL_461472 (CHEMBL927483) Binding affinity at human LXRbeta
- ChEMBL_461473 (CHEMBL927484) Binding affinity at human LXRalpha
- ChEMBL_461636 (CHEMBL928754) Antagonist activity at mouse CXCR3
- ChEMBL_461899 (CHEMBL929035) Binding affinity at human MC4R
- ChEMBL_463082 (CHEMBL928992) Binding affinity at human ERG
- ChEMBL_463844 (CHEMBL934038) Binding affinity at 5HT2A receptor
- ChEMBL_463845 (CHEMBL934039) Binding affinity at 5HT2B receptor
- ChEMBL_463846 (CHEMBL934040) Binding affinity at 5HT2C receptor
- ChEMBL_465785 (CHEMBL948147) Antagonist activity at CCR8 receptor
- ChEMBL_471738 (CHEMBL921010) Agonist activity at CB1 receptor
- ChEMBL_471739 (CHEMBL921011) Agonist activity at CB2 receptor
- ChEMBL_474640 (CHEMBL921839) Binding affinity at 5HT1A receptor
- ChEMBL_474642 (CHEMBL920900) Binding affinity at 5HT2A receptor
- ChEMBL_474644 (CHEMBL920902) Binding affinity at 5HT2C receptor
- ChEMBL_478517 (CHEMBL922479) Agonist activity at human PPARalpha
- ChEMBL_478518 (CHEMBL922480) Agonist activity at human PPARgamma
- ChEMBL_479541 (CHEMBL931537) Binding affinity at progesterone receptor
- ChEMBL_479548 (CHEMBL931544) Binding affinity at mineralocorticoid receptor
- ChEMBL_479549 (CHEMBL931545) Binding affinity at androgen receptor
- ChEMBL_479602 (CHEMBL926798) Agonist activity at TPO receptor
- ChEMBL_487758 (CHEMBL1009490) Binding affinity at 5HT2B receptor
- ChEMBL_487759 (CHEMBL1009491) Binding affinity at 5HT2C receptor
- ChEMBL_491617 (CHEMBL945388) Agonist activity at GHS receptor
- ChEMBL_498031 (CHEMBL1000234) Agonist activity at PPARalpha receptor
- ChEMBL_502100 (CHEMBL983225) Agonist activity at rat PPARalpha
- ChEMBL_502101 (CHEMBL983226) Agonist activity at mouse PPARalpha
- ChEMBL_514046 (CHEMBL979069) Agonist activity at sst4 receptor
- ChEMBL_514050 (CHEMBL979073) Agonist activity at 5HT1A receptor
- ChEMBL_514051 (CHEMBL979074) Agonist activity at 5HT2B receptor
- ChEMBL_514296 (CHEMBL979126) Agonist activity at NK1 receptor
- ChEMBL_520083 (CHEMBL943687) Agonist activity at mouse PPARalpha
- ChEMBL_520085 (CHEMBL943689) Agonist activity at dog PPARalpha
- ChEMBL_523646 (CHEMBL998017) Agonist activity at androgen receptor
- ChEMBL_523924 (CHEMBL1001517) Activity at Cav 1.2 channel
- ChEMBL_531312 (CHEMBL989724) Agonist activity at CB1 receptor
- ChEMBL_537453 (CHEMBL990618) Binding affinity at 5HT2A receptor
- ChEMBL_537454 (CHEMBL990619) Binding affinity at 5HT2B receptor
- ChEMBL_537455 (CHEMBL990620) Binding affinity at 5HT6 receptor
- ChEMBL_537456 (CHEMBL990621) Binding affinity at 5HT2C receptor
- ChEMBL_537471 (CHEMBL990636) Antagonist activity at NK1 receptor
- ChEMBL_545993 (CHEMBL1027697) Antagonist activity at mGlu1 receptor
- ChEMBL_545994 (CHEMBL1027698) Antagonist activity at mGlu2 receptor
- ChEMBL_545995 (CHEMBL1027699) Antagonist activity at mGlu3 receptor
- ChEMBL_545996 (CHEMBL1027700) Antagonist activity at mGlu4 receptor
- ChEMBL_545997 (CHEMBL1027701) Antagonist activity at mGlu7 receptor
- ChEMBL_545998 (CHEMBL1027702) Antagonist activity at mGlu8 receptor
- ChEMBL_552261 (CHEMBL995591) Agonist activity at human PXR
- ChEMBL_555588 (CHEMBL965635) Binding affinity at mouse MC4R
- ChEMBL_555589 (CHEMBL965636) Binding affinity at mouse MC3R
- ChEMBL_555591 (CHEMBL965638) Binding affinity at rat MC3R
- ChEMBL_559139 (CHEMBL1012084) Antagonist activity at human CCR2
- ChEMBL_564428 (CHEMBL964233) Binding affinity at 5HT3 receptor
- ChEMBL_591060 (CHEMBL1052813) Agonist activity at recombinant GluR5
- ChEMBL_591061 (CHEMBL1052814) Agonist activity at recombinant GluR6
- ChEMBL_594037 (CHEMBL1045844) Antagonist activity at human CCR8
- ChEMBL_598574 (CHEMBL1043566) Agonistic activity at DRD2 receptor
- ChEMBL_598575 (CHEMBL1043567) Agonistic activity at DRD3 receptor
- ChEMBL_598675 (CHEMBL1050756) Agonist activity at glucagon receptor
- ChEMBL_604791 (CHEMBL1072585) Antagonist activity at human CCR5
- ChEMBL_608753 (CHEMBL1067766) Agonist activity at 5HT1A receptor
- ChEMBL_612722 (CHEMBL1069594) Antagonist activity at P2X1 receptor
- ChEMBL_612723 (CHEMBL1069595) Antagonist activity at P2X2 receptor
- ChEMBL_612724 (CHEMBL1069596) Antagonist activity at P2X4 receptor
- ChEMBL_612725 (CHEMBL1069597) Antagonist activity at P2X5 receptor
- ChEMBL_612726 (CHEMBL1069598) Antagonist activity at P2X6 receptor
- ChEMBL_612727 (CHEMBL1069599) Antagonist activity at P2X7 receptor
- ChEMBL_614259 (CHEMBL1106922) Activity at histamine H1 receptor
- ChEMBL_625154 (CHEMBL1115175) Agonist activity at 5HT2C receptor
- ChEMBL_625163 (CHEMBL1115184) Binding affinity at M1 receptor
- ChEMBL_625299 (CHEMBL1109737) Agonist activity at 5HT2B receptor
- ChEMBL_625301 (CHEMBL1109739) Agonist activity at 5HT2A receptor
- ChEMBL_625738 (CHEMBL1104415) Binding affinity at 5HT1A receptor
- ChEMBL_625777 (CHEMBL1106227) Antagonist activity at human mGluR1
- ChEMBL_625778 (CHEMBL1106228) Antagonist activity at human mGluR5
- ChEMBL_625779 (CHEMBL1106229) Antagonist activity at rat mGluR1
- ChEMBL_627990 (CHEMBL1105511) Agonist activity at GluA1 receptor
- ChEMBL_627991 (CHEMBL1105512) Agonist activity at GluA2 receptor
- ChEMBL_627992 (CHEMBL1105513) Agonist activity at GluA3 receptor
- ChEMBL_630082 (CHEMBL1110002) Agonist activity at human BRS3
- ChEMBL_630084 (CHEMBL1110004) Agonist activity at mouse BRS3
- ChEMBL_633002 (CHEMBL1118227) Antagonist activity at TRPA1 channel
- ChEMBL_634206 (CHEMBL1119788) Antagonist activity at human TRPV1
- ChEMBL_634710 (CHEMBL1118795) Agonist activity at alpha4beta2 nAChR
- ChEMBL_643983 (CHEMBL1211882) Antagonist activity at human mGLUR1
- ChEMBL_649966 (CHEMBL1219664) Antagonist activity at androgen receptor
- ChEMBL_649967 (CHEMBL1219665) Antagonist activity at progesterone receptor
- ChEMBL_649968 (CHEMBL1219666) Antagonist activity at estrogen receptor
- ChEMBL_649973 (CHEMBL1219671) Antagonist activity at glucocorticoid receptor
- ChEMBL_651959 (CHEMBL1227632) Antagonist activity at oxytocin receptor
- ChEMBL_661952 (CHEMBL1252556) Agonist activity at CB2 receptor
- ChEMBL_662951 (CHEMBL1250810) Antagonist activity at MCH1 receptor
- ChEMBL_675610 (CHEMBL1273918) Agonist activity at motilin receptor
- ChEMBL_684663 (CHEMBL1285630) Agonist activity at GluR2 receptor
- ChEMBL_71097 (CHEMBL674945) Antagonist activity at glucocorticoid receptor
- ChEMBL_718565 (CHEMBL1680471) Antagonist activity at mGlu1 receptor
- ChEMBL_718566 (CHEMBL1680472) Antagonist activity at mGlu2 receptor
- ChEMBL_718567 (CHEMBL1680473) Antagonist activity at mGlu7 receptor
- ChEMBL_718713 (CHEMBL1680932) Agonist activity at human GPR109b
- ChEMBL_718716 (CHEMBL1680935) Agonist activity at rat GPR109a
- ChEMBL_718717 (CHEMBL1680936) Agonist activity at mouse GPR109a
- ChEMBL_726359 (CHEMBL1687491) Antagonist activity at mouse CXCR3
- ChEMBL_726360 (CHEMBL1687492) Antagonist activity at rat CXCR3
- ChEMBL_726362 (CHEMBL1687494) Antagonist activity at human CXCR3
- ChEMBL_735873 (CHEMBL1694377) Antagonist activity at N-cadherin
- ChEMBL_743285 (CHEMBL1767484) Agonist activity at P2Y2 receptor
- ChEMBL_743286 (CHEMBL1767485) Agonist activity at P2Y4 receptor
- ChEMBL_743287 (CHEMBL1767486) Agonist activity at P2Y6 receptor
- ChEMBL_745347 (CHEMBL1775467) Agonist activity at M2 receptor
- ChEMBL_745348 (CHEMBL1775468) Agonist activity at M3 receptor
- ChEMBL_745349 (CHEMBL1775469) Agonist activity at M4 receptor
- ChEMBL_745350 (CHEMBL1775470) Agonist activity at M5 receptor
- ChEMBL_746070 (CHEMBL1775457) Agonist activity at CB2 receptor
- ChEMBL_748957 (CHEMBL1781405) Agonist activity at motilin receptor
- ChEMBL_749287 (CHEMBL1785222) Antagonist activity at NK1 receptor
- ChEMBL_749913 (CHEMBL1786743) Antagonist activity at human mGluR1
- ChEMBL_749914 (CHEMBL1786744) Antagonist activity at rat mGluR1
- ChEMBL_749915 (CHEMBL1786745) Antagonist activity at human mGluR5
- ChEMBL_750607 (CHEMBL1786471) Partial agonist activity at PPARdelta
- ChEMBL_751026 (CHEMBL1786811) Agonist activity at human P2Y2
- ChEMBL_751027 (CHEMBL1786812) Agonist activity at human P2Y4
- ChEMBL_766634 (CHEMBL1827200) Antagonist activity at S1P1 receptor
- ChEMBL_766635 (CHEMBL1827201) Antagonist activity at S1P3 receptor
- ChEMBL_766637 (CHEMBL1827203) Antagonist activity at S1P5 receptor
- ChEMBL_766639 (CHEMBL1827205) Antagonist activity at S1P2 receptor
- ChEMBL_770289 (CHEMBL1833598) Antagonist activity at alpha4beta1 integrin
- ChEMBL_774918 (CHEMBL1913363) Agonist activity at S1P1 receptor
- ChEMBL_774919 (CHEMBL1913364) Agonist activity at S1P2 receptor
- ChEMBL_774921 (CHEMBL1913366) Agonist activity at S1P5 receptor
- ChEMBL_788421 (CHEMBL1918186) Agonist activity at estrogen receptor
- ChEMBL_789638 (CHEMBL1924723) Antagonist activity at human CCR2
- ChEMBL_795615 (CHEMBL1936045) Antagonist activity at progesterone receptor
- ChEMBL_796328 (CHEMBL1937643) Antagonist activity at 5HT2B receptor
- ChEMBL_796444 (CHEMBL1937759) Agonist activity at dog PPARalpha
- ChEMBL_796445 (CHEMBL1937760) Agonist activity at dog PPARgamma
- ChEMBL_796446 (CHEMBL1937761) Agonist activity at dog PPARdelta
- ChEMBL_796450 (CHEMBL1937765) Agonist activity at rat PPARalpha
- ChEMBL_796451 (CHEMBL1937766) Agonist activity at rat PPARgamma
- ChEMBL_796453 (CHEMBL1937768) Agonist activity at mouse PPARalpha
- ChEMBL_796454 (CHEMBL1937769) Agonist activity at mouse PPARgamma
- ChEMBL_796455 (CHEMBL1937770) Agonist activity at mouse PPARdelta
- ChEMBL_797513 (CHEMBL1943343) Agonist activity at rat GPR40
- ChEMBL_797514 (CHEMBL1943344) Agonist activity at mouse GPR40
- ChEMBL_798318 (CHEMBL1943806) Agonist activity at human HM74A
- ChEMBL_802539 (CHEMBL1952575) Agonist activity at human S1P5R
- ChEMBL_815097 (CHEMBL2024822) Antagonist activity at alpha4beta2 nAChR
- ChEMBL_815098 (CHEMBL2024823) Antagonist activity at alpha1 nAChR
- ChEMBL_815374 (CHEMBL2026878) Antagonist activity at alpha1 nAChR
- ChEMBL_815375 (CHEMBL2026879) Antagonist activity at alpha4beta2 nAChR
- ChEMBL_818643 (CHEMBL2033032) Antagonist activity at Smo receptor
- ChEMBL_819765 (CHEMBL2034277) Agonist activity at SIP3 receptor
- ChEMBL_819766 (CHEMBL2034278) Agonist activity at SIP1 receptor
- ChEMBL_819961 (CHEMBL2032548) Antagonist activity at mouse CCR2
- ChEMBL_819962 (CHEMBL2032549) Antagonist activity at rat CCR2
- ChEMBL_820674 (CHEMBL2037945) Agonist activity at human GPR109b
- ChEMBL_820675 (CHEMBL2037946) Agonist activity at rat GPR109a
- ChEMBL_820676 (CHEMBL2037947) Agonist activity at mouse GPR109a
- ChEMBL_830238 (CHEMBL2060789) Agonist activity at mouse GPR120
- ChEMBL_830642 (CHEMBL2061535) Antagonist activity at rat CFR1R
- ChEMBL_830654 (CHEMBL2061589) Antagonist activity at human CCR3
- ChEMBL_834193 (CHEMBL2072933) Agonist activity at human PPARalpha
- ChEMBL_834194 (CHEMBL2072934) Agonist activity at rat PPARalpha
- ChEMBL_850286 (CHEMBL2150706) Agonist activity at monkey GPR81
- ChEMBL_850287 (CHEMBL2150707) Agonist activity at dog GPR81
- ChEMBL_850288 (CHEMBL2150708) Agonist activity at rat GPR81
- ChEMBL_850289 (CHEMBL2150709) Agonist activity at mouse GPR81
- ChEMBL_851151 (CHEMBL2157808) Agonist activity at alpha7 nAChR
- ChEMBL_854925 (CHEMBL2162809) Antagonist activity at CCR3 receptor
- ChEMBL_855078 (CHEMBL2160640) Inhibition at human recombinant FAPalpha
- ChEMBL_855080 (CHEMBL2160642) Inhibition at human recombinant POP
- ChEMBL_856035 (CHEMBL2162152) Antagonist activity at 5HT2A receptor
- ChEMBL_858208 (CHEMBL2167671) Antagonist activity at 5HT2A receptor
- ChEMBL_862590 (CHEMBL2173986) Antagonist activity at mGlu5 receptor
- ChEMBL_873650 (CHEMBL2188766) Antagonist activity at progesterone receptor
- ChEMBL_873651 (CHEMBL2188767) Antagonist activity at mineralocorticoid receptor
- ChEMBL_879207 (CHEMBL2208520) Agonist activity at ghrelin receptor
- ChEMBL_883203 (CHEMBL2212129) Antagonist activity at human TRalpha1
- ChEMBL_883204 (CHEMBL2212130) Antagonist activity at human TRbeta1
- ChEMBL_884984 (CHEMBL2211244) Antagonist activity at rat mGluR1
- ChEMBL_884985 (CHEMBL2211245) Antagonist activity at human mGluR5
- ChEMBL_884986 (CHEMBL2211246) Antagonist activity at human mGluR1
- ChEMBL_886913 (CHEMBL2211869) Agonist activity at S1P4 receptor
- ChEMBL_886914 (CHEMBL2211870) Agonist activity at S1P5 receptor
- ChEMBL_933765 (CHEMBL2321101) Agonist activity at mouse TLR7
- ChEMBL_938597 (CHEMBL2327057) Antagonist activity at rat TRPV4
- ChEMBL_959853 (CHEMBL2383517) Antagonist activity at human MDM2
- ChEMBL_964985 (CHEMBL2396018) Antagonist activity at rat CCR1
- ChEMBL_973264 (CHEMBL2412443) Agonist activity at human VDR
- ChEMBL_985965 (CHEMBL2432197) Agonist activity at mouse GPR142